The nation of Zimbabwe has declined a substantial American health deal valued at $367m (272 million pounds) spanning five years because of the United States' request for confidential information.
The decision came to light following a government memo from December was disclosed, which showed President Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesman later stated that the United States was requesting health data for research and commercial gain but was not willing to guarantee the benefits from future vaccines.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued negotiations to find a deal agreeable to all parties so the country's vital HIV programme can continue.
Broader Context
Zimbabwe's decision comes after a similar case in Kenya, where a court suspended a related deal with the US following legal challenges were raised about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government deals to boost openness and responsibility.
According to reports, 16 nations in Africa have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration could have provided significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information indefinitely, with no corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the end products would be accessible to our population should a future disease outbreak emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were disrupting frameworks previously set up via the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with potential pandemics.
"This system is intended to guarantee that when a country provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.
"We are open to continued discussions with our US partners on how future collaboration might be arranged in a manner that honours the sovereignty and dignity of both nations."
Medical Community Response
Medical experts said it recognised the government's concerns, but suggested that talks need to persist considering much of the country's Aids initiatives were funded by external financing.
"If specific concerns arise, such as those involving information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it commented.
This impasse emphasises the continuing debate between accepting vital foreign assistance and protecting a country's data in an ever more interconnected world.